Medical Dialogues6d
FDA Expands Approval of wearable furosomide delvery system for CKD-Related Edema
The US Food and Drug Administration (FDA) has broadened the approval of Furoscix (furosemide injection) to treat edema in ...
Hosted on MSN23d
FDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKD
The Furoscix 80 mg/10 ml subcutaneous injection is intended for oedema in adult CKD patients, including those with nephrotic syndrome. scPharmaceuticals CEO John Tucker stated: "We are thrilled to ...
Nature2mon
Tacrolimus effective in steroid-dependent minimal change nephrotic syndrome
A recent study found that a 24-week course of oral tacrolimus (along with tapering doses of prednisone) might be an effective alternative to ciclosporin in Chinese adults with steroid-dependent ...
Nature1y
NPHS2 (Podocin) Mutations in Nephrotic Syndrome. Clinical Spectrum and Fine Mechanisms
Nephrotic syndrome (NS) is the most frequent cause of proteinuria in children and is emerging as a leading cause of uremia. Molecular studies in families with recessive NS have led to the ...
Yahoo Finance24d
FDA approves scPharmaceuticals’ Furoscix sNDA for oedema in CKD
The US Food and Drug Administration (FDA) has approved scPharmaceuticals’ supplemental new drug application (sNDA) for Furoscix(furosemide), expanding its indication to include oedema treatment ...